Novel use of burosumab in refractory iron-induced FGF23-mediated hypophosphataemic osteomalacia

Slični predmeti

• Treating ‘osteoporosis’: a near miss in an unusual case of FGF-23-mediated hypophosphataemic osteomalacia
  od: Mike Lin, i dr.
  Izdano: (2022-11-01)
• A Rare Case of Hypophosphataemic Osteomalacia in von Recklinghausen Neurofibromatosis
  od: Yasmine Makhlouf, i dr.
  Izdano: (2021-05-01)
• Tumour-induced osteomalacia: 18 months of 2-weekly burosumab treatment
  od: L Aliberti, i dr.
  Izdano: (2023-01-01)
• Burosumab - new potent treatment for X-linked hypophosphatemia and tumor-induced osteomalacia
  od: Magda Wojtuś, i dr.
  Izdano: (2023-07-01)
• Selective blood sampling for FGF-23 in tumor-induced osteomalacia
  od: Hans-Christof Schober, i dr.
  Izdano: (2017-10-01)